Çàðåãèñòðèðîâàòüñÿ

Ïîõîæèå òåìû

  1. Óâàæàåìàÿ Ëþäìèëà Èãîðåâíà! Ïîìîãèòå ìíå ïîæàëóéñòà. Ñïðîñèòü íå ó êîãî. ß...
    îò Ñàøà â ðàçäåëå Ãèíåêîëîã-àêóøåð, áåðåìåííîñòü, ðîäû
    Îòâåòîâ: 1
    : 31.08.2004, 04:30
  2. Îòâåòîâ: 2
    : 18.08.2004, 18:10
  3. Óâàæàåìàÿ Ëþäìèëà Èãîðåâíà! Ïîìîãèòå, ïîæàëóéñòà, â ìîèõ ñîìíåíèÿõ. Ïîñëåäí...
    îò Îëüãà â ðàçäåëå Ãèíåêîëîã-àêóøåð, áåðåìåííîñòü, ðîäû
    Îòâåòîâ: 1
    : 14.08.2004, 01:50
  4. Îòâåòîâ: 1
    : 22.07.2004, 17:40
  5. Îòâåòîâ: 4
    : 13.07.2004, 00:50
  1. ëþáîâü
    #1
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìàÿ Ëþäìèëà Ìèõàéëîâíà1 Ïîìîãèòå ïîæàëóéñòà ðàçîáðàòüñÿ â äîáàâêå ìåãàìèí. ×òî òàêîå êëèíîïòèëîëèò è íàñêîëüêî ìîæíî äîâåðÿòü àííîòàöèè ê äîáàâêå7

  2. Øàïîâàëîâà Ë.Ì.
    #2
    ×èòàòåëü Íåäóã.Ðó
    Çäðàâñòâóéòå, Ëþáîâü. Ê ñîæàëåíèþ Ýòîé äîáàâêè íåò â ôåäåðàëüíîì ðååñòðå, à àíîòàöèè ó ìåíÿ òîæå íåò - ïðèøëèòå îïèñàíèå, ìîæåò áûòü ðàçáåðåìñÿ.

  3. Ëþáîâü
    #3
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìàÿ Ëþäìèäà Ìèõàéëîâíà ! Ìåãàìèí ñâîé ñàéò http: // megamin. ru  àííîòàöèè óêàçàí ðåãèñòðàöèîííûé íîìåð 003674. Í. 191. 01. 2002 åñëè âîçìîæíî ïîñìîòðèòå ïîæàëóéñòà, òàê êàê ÿ íå çíàþ, ÷òî èç àííîòàöèè ê äîáàâêå âûïèñàòü

  4. Øàïîâàëîâà Ë.Ì.
    #4
    ×èòàòåëü Íåäóã.Ðó
    Çäðàâñòâóéòå, Ëþáîâü. Íà ñàéòå óêàçàíî åâðîïåéñêîå, à íå ðîññèéñêîå ðåãèñòðàöèîííîå ñâèäåòåëüñòâî, ñëåäîâàòåëüíî â Ðîññèè ýòîò ïðåïàðàò âñå- æå íå çàðåãèñòðèðîâàí.
     ðàçäåëå "Ìåõàíèçìû äåéñòâèÿ èññëåäîâàíèÿ èí âèòðî" ãîâîðèòñÿ î ìåõàíè÷åñêîì ïîâðåæäåíèè êëåòîê ïðè âûñîêèõ êîíöåíòðàöèÿ ýòîé ãëèíû (äëÿ íàãëÿäíîñòè ïîïðîáóéòå íàìàçàòü ãëèíîé ðóêó - êîæà ïîäñîõíåò è ñìîðùèòñÿ), òåì áîëåå, ÷òî â êðîâü â òàêèõ êîíöåíòðàöèÿõ öåîëèòû ïîïàäàòü íå ìîãóò. ß, êîíå÷íî, ïîñîâåòóþñü ñî ñïåöèàëèñòîì â îëàñòè ýëåêòðîõèìèè, íî íà ìîé âçãëÿä ðàññóæäåíèÿ îá àíòèîêñèäàíòíûõ ñâîéñòâàõ - ïîëíàÿ ÷óøü.  ðàçäåëå "êëèíè÷åñêèå èñïûòàíèÿ" íè î êàêèõ èñïûòàíèÿõ íåè ðå÷è - îïèñàíèÿ åäèíè÷íûõ ñëó÷àåâ âîîáùå áåçî âñÿêîãî êîíòðîëÿ.
     ðàçäåëå íàó÷íûå ïóáëèêàöèè:
    Ñòàòüè "Immunostimulatory effect of natural clinoptilolite as a possible mechanism of antimetastatic ability" íå ñóùåñòâóåò â ïðèðîäå (pubmed. gov)
    Â äðóãîé ñòàòüå ãîâîðèòüñÿ íå î ïðîòèâîîïóõîëåâûõ ñâîéñòâàõ , à òîëüêî î âîçìîæíîñòè áîðüáû ñ äèàððååé ïðè õèìèîòåðàïèè - òåêñò ðåôåðàòà ïðèâîæó íèæå.
    Natural zeolite clinoptilolite: new adjuvant in anticancer therapy.

    Pavelic K, Hadzija M, Bedrica L, Pavelic J, Dikic I, Katic M, Kralj M, Bosnar MH, Kapitanovic S, Poljak- Blazi M, Krizanac S, Stojkovic R, Jurin M, Subotic B, Colic M.

    Ruder Boskovic Institute, Division of Molecular Medicine, Zagreb, Croatia. pavelic@rudjer. irb. hr

    Natural silicate materials, including zeolite clinoptilolite, have been shown to exhibit diverse biological activities and have been used successfully as a vaccine adjuvant and for the treatment of diarrhea. We report a novel use of finely ground clinoptilolite as a potential adjuvant in anticancer therapy. Clinoptilolite treatment of mice and dogs suffering from a variety of tumor types led to improvement in the overall health status, prolongation of life- span, and decrease in tumors size. Local application of clinoptilolite to skin cancers of dogs effectively reduced tumor formation and growth. In addition, toxicology studies on mice and rats demonstrated that the treatment does not have negative effects. In vitro tissue culture studies showed that finely ground clinoptilolite inhibits protein kinase B (c- Akt), induces expression of p21WAF1/ CIP1 and p27KIP1 tumor suppressor proteins, and blocks cell growth in several cancer cell lines. These data indicate that clinoptilolite treatment might affect cancer growth by attenuating survival signals and inducing tumor suppressor genes in treated cells.

    Publication Types:
    Clinical Trial

    PMID: 11434724 [PubMed - indexed for MEDLINE]

    Â ñòàòüå The effect of the zeolite clinoptilolite on serum chemistry and hematopoiesis in mice.
    Ãîâîðèòüñÿ î íåñòàáèëüíîì âëèÿíèè èñêóñòâåííûõ è íàòóðàëüíûõ öåîëèòîâ íà óðîâåíü êàëèÿ è íàòðèÿ â êðîâè æèâîòíûõ (òåêñò ðåôåðàòà òîæå ìîæíî ïîñìîòðåòü â pubmed. gov).
    Òàê, ÷òî íà ìîé âçãëÿä ñëèøêîì ìíîãî ïîäòàñîâîê è ïåðåäåðãèâàíèÿ, òåì áîëåå, ÷òî àëþìèíèé ìîæåò ïðèâîäèòü ê ðàçðóøåíèþ êîñòåé è ïîâûøàåò óãðîçó ðàçâèòèÿ ñòàð÷åñêîãî ñëàáîóìèÿ.

  5. Åâãåíèé
    #5
    ×èòàòåëü Íåäóã.Ðó
    Ìåãàìèí çàðåãåñòðèðîâàí â Ìèíèñòåðñòâå Çäðàâîîõðàíåíèÿ ÐÔ Ðåãèñòðàöèîííîå óäîñòîâåðåíèå
    ¹ 003674. È. 191. 01. 2002
    Ïî ïîâîäó ðàçðóøåíèÿ êîñòåé è ñòàð÷åñêîãî ñëàáîóìèÿ - ÂÎÒ ÝÒÎ ×ÓØÜ- ÏÎËÍÀß, ïðåïàðàò ïðîøåë âñå ñîîòâåòñòâóþùèå èññëåäîâàíèÿ.

Êëèíèêà ñòîìàòîëîãèè è êîñìåòîëîãèè â Ìîñêâå

Ìåòêè ýòîé òåìû

Âàøè ïðàâà

  • Âû ìîæåòå ñîçäàâàòü íîâûå òåìû
  • Âû ìîæåòå îòâå÷àòü â òåìàõ
  • Âû íå ìîæåòå ïðèêðåïëÿòü âëîæåíèÿ
  • Âû íå ìîæåòå ðåäàêòèðîâàòü ñâîè ñîîáùåíèÿ
  •